Cargando…

Building medical knowledge from real world registries: The case of heart failure

Detalles Bibliográficos
Autores principales:	Aimo, Alberto, Seghieri, Chiara, Nuti, Sabina, Emdin, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020859/ https://www.ncbi.nlm.nih.gov/pubmed/29955669 http://dx.doi.org/10.1016/j.ijcha.2018.03.008

Ejemplares similares

Rituximab as a novel treatment for heart failure: evidence from a case series
por: Aimo, Alberto, et al.
Publicado: (2019)

Biomarkers for the diagnosis and management of heart failure
por: Castiglione, Vincenzo, et al.
Publicado: (2021)

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin
por: Aimo, Alberto, et al.
Publicado: (2022)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Current and emerging drug targets in heart failure treatment
por: Ghionzoli, Nicolò, et al.
Publicado: (2021)

Applying discrete choice modelling in a priority setting: an investigation of public preferences for primary care models
por: Seghieri, Chiara, et al.
Publicado: (2013)

Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block
por: Aimo, Alberto, et al.
Publicado: (2021)

Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
por: Castiglione, Vincenzo, et al.
Publicado: (2023)

Economic Burden of Heart Failure in Asian Countries Based on Real-world Data
por: Chung, Hyemoon, et al.
Publicado: (2021)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

“Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
por: Simpson, Joanne, et al.
Publicado: (2019)

Toward a New Heart Failure Registry in Korea
por: Youn, Jong-Chan, et al.
Publicado: (2017)

A turnaround strategy: improving equity in order to achieve quality of care and financial sustainability in Italy
por: Cafagna, Gianluca, et al.
Publicado: (2018)

Building Process-Oriented Data Science Solutions for Real-World Healthcare
por: Fernandez-Llatas, Carlos, et al.
Publicado: (2022)

Intracoronary Delivery of Mitochondria to Prevent Ischemia–Reperfusion Injury: Challenging Pathway From Bench to Bedside
por: Aimo, Alberto, et al.
Publicado: (2020)

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2023)

How do hospitalization experience and institutional characteristics influence inpatient satisfaction? A multilevel approach
por: Murante, Anna Maria, et al.
Publicado: (2014)

Socio-demographic determinants of women’s satisfaction with prenatal and delivery care services in Italy
por: Tocchioni, Valentina, et al.
Publicado: (2018)

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry
por: Savarese, G., et al.
Publicado: (2020)

Utilisation of real-world data from heart failure registries in OECD countries - A systematic review()
por: Du, Xiaoyang, et al.
Publicado: (2018)

Novel Drug Targets for Central Apneas in Heart Failure: On the Road
por: Borrelli, Chiara, et al.
Publicado: (2021)

Comparing regional models of congenital bleeding disorders: preliminary steps in the Italian context
por: Nuti, Sabina, et al.
Publicado: (2017)

Prevalence and Challenges of Hypertensive Heart Diseases in the Real World
por: Hu, Kai, et al.
Publicado: (2019)

Building the new digital world: launch of the European Heart Journal - Digital Health
por: Cowie, Martin R
Publicado: (2020)

ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
por: Aspromonte, Nadia, et al.
Publicado: (2017)

The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations
por: Núñez, Julio, et al.
Publicado: (2021)

Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
por: Chianca, Michela, et al.
Publicado: (2022)

Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2019)

Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

International Journal of Heart Failure: a New Journal for the Advancement of Knowledge, Experience and Science in the Field of Heart Failure
por: Park, Seong-Mi
Publicado: (2019)

Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences
por: Saccaro, Luigi F., et al.
Publicado: (2021)

Heart failure guidelines implementation: Lifting barriers using registries and networks
por: Keramida, Kalliopi, et al.
Publicado: (2020)

Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter?
por: Fabiani, Iacopo, et al.
Publicado: (2023)

Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2019)

Correction for: Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2019)

Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure
por: Mirizzi, Gianluca, et al.
Publicado: (2016)

Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the Korean Acute Heart Failure (KorAHF) Registry
por: Oh, Jaewon, et al.
Publicado: (2019)

Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2020)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_giij8mq49q5icljevefdqugq1u